Clik here to view.
AmpliPhi Biosciences Announces Appointment of Alexander Gaidamaka as Vice...
SAN DIEGO & RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY AmpliPhi Biosciences Corporation (NYSE: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat...
View ArticleClik here to view.
GN ReSound Opens Johor Malaysia Factory and Distribution Center to Support...
COPENHAGEN, Denmark Today, GN ReSound®, a global leader in innovative hearing technologies, hosted an official opening ceremony for the company’s newest manufacturing and distribution facility in...
View ArticleClik here to view.
Enrollment Begins in Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced that the first patient has been enrolled and treated in the ADRESU trial, a late phase, physician-initiated Japanese clinical trial to...
View ArticleClik here to view.
Chugai’s Bispecific Antibody “ACE910″ for the Treatment of Hemophilia A...
TOKYO Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; Chairman & CEO: Osamu Nagayama] (hereafter, “Chugai”) announced today that the US Food and Drug Administration (FDA) has...
View ArticleClik here to view.
Alvogen Launches the First Generic Exelon® Patch in the United States
PINE BROOK, N.J. Today, Alvogen has launched the first generic equivalent of Exelon® patch (rivastigmine transdermal system) in the United States. The product will be marketed by Alvogen in three...
View ArticleClik here to view.
Yabao Pharmaceuticals and University of South Australia Announce New Joint...
BEIJING & ADELAIDE, Australia One of China’s leading pharmaceutical companies, Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351) and South Australia’s largest university, the...
View ArticleClik here to view.
Starpharma Signs Drug Delivery License with AstraZeneca
MELBOURNE, Australia Starpharma (ASX: SPL) (OTCQX: SPHRY) today announced the signing of a licensing agreement with global pharmaceutical company AstraZeneca. The agreement enables the development...
View ArticleClik here to view.
SanifitがシリーズC資金調達ラウンドで3660万ユーロ（4130万ドル）を調達
スペイン・パルマデマヨルカ 臨床段階のバイオ製薬企業Laboratoris Sanifit S.L.は本日、シリーズC資金調達ラウンドで3660万ユーロ（4130万ドル）を調達したと発表しました。当社はSNF472の開発に傾注しています。SNF472は血液透析を受けている末期腎不全（ESRD)患者で、石灰化に関連した心血管疾患の治療を目的とした治験薬です。 投資を主導したのはYsios...
View ArticleClik here to view.
Samples Sought for Caldera Health “Pee in a Pot” Prostate Test
AUCKLAND, New Zealand Men with suspected prostate cancer are being urged to help Caldera Health perfect its urine diagnostic test. Molecular diagnostic firm Caldera Health is in the final stages of...
View ArticleClik here to view.
ジーエヌリサウンド、マレーシア・ジョホールに製造・流通センターを開設し、会社の継続的成長をサポート
デンマーク・コペンハーゲン （ビジネスワイヤ） — 革新的補聴器技術の世界的リーダー企業であるジーエヌリサウンドは本日、マレーシア・ジョホール州クライジャヤに最近設立した製造・流通施設の公式開館式を開催しました。5000m2 のこの新しい施設により、ジーエヌリサウンドの世界的な生産能力が拡大するとともに、この施設はこの地域の新たな流通拠点となります。 このSmart News...
View ArticleClik here to view.
GN ReSound开设马来西亚柔佛工厂暨配送中心，以支持公司持续发展
丹麦哥本哈根 (美国商业资讯)–今天，创新听力技术领域的全球领导者GN ReSound®在马来西亚柔佛古来再也县为该公司的最新生产配送工厂举行了正式的开业典礼。这座占地5,000平方米的新设施将扩大GN ReSound的全球产能，并将作为该地区的新配送中心。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
ReSound®重返国际消费类电子产品展览会，展示不断扩大的智能助听器组合
柏林 (美国商业资讯)–ReSound今天欣然宣布，该公司已重返在德国柏林举办的全球最大的国际消费类电子产品展览会IFA（德国柏林消费电子展），并展示该公司不断扩大的屡获殊荣的创新智能听力(Smart Hearing)技术组合。 ReSound在本年度举办的活动包括互动演示全球首个为iPhone打造的完整系列助听器ReSound...
View ArticleClik here to view.
Clik here to view.
Novocure Announces Optune Now Available at more than 200 Leading Cancer...
NEW YORK Novocure announced today that more than 200 treatment centers in the United States have been certified to prescribe Optune to patients with recurrent glioblastoma (GBM). GBM is the most...
View ArticleClik here to view.
Cytori Appoints VP and General Manager of Cell Therapy
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Mr. John D. Harris has been appointed as Vice President and General Manager of Cell Therapy, a newly created role to be based...
View ArticleClik here to view.
Merck and Samsung Bioepis Announce Approval of BRENZYS™ (Etanercept), a...
KENILWORTH, N.J. & SEOUL, South Korea Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced the approval of BRENZYS™ (etanercept), a...
View ArticleClik here to view.
Walvax Biotechnology Selects Medidata’s Cloud-Based Platform to Advance...
NEW YORK Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its industry-leading technology platform has been...
View ArticleClik here to view.
AstraZeneca Presents Further Evidence for the Potential of AZD9291 in...
LONDON AstraZeneca today announced updated data on AZD9291 in first-line patients with epidermal growth factor receptor mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC) and...
View ArticleClik here to view.
Chugai’s ALK Inhibitor “Alectinib,” New Drug Application Submitted for ALK...
TOKYO Chugai Pharmaceutical Co., Ltd. [Main Office: Chuo-ku, Tokyo. Chairman & CEO: Osamu Nagayama] (Chugai) (TOKYO:4519) and F. Hoffmann-La Roche Ltd. [Head Office: Basel, Switzerland. CEO:...
View ArticleClik here to view.
リサウンド® がスマート・ヒアリング補聴器の製品群を拡大し、再び国際コンシューマ・エレクトロニクス展に参加
ベルリン （ビジネスワイヤ） — リサウンドは本日、ドイル・ベルリンで開催される世界最大の国際コンシューマ・エレクトロニクス展のIFAに再び参加し、拡大する革新的受賞スマート・ヒアリング技術ポートフォリオを紹介することを発表します。 今年のリサウンドの展示には、iPhone対応（Made for iPhone）補聴器であるリサウンド・リンクス2（ReSound...
View Article